Mouth Cancer – Where Are We Post Covid-19?

Online content includes 120 days access from the date of purchase.
All purchases are for a single user only.

MOUTH CANCER – WHERE ARE WE POST COVID-19?

The impact of a restricted access to primary care services during the Covid-19 pandemic is manifesting in 2022 in the form of mouth cancers that are relatively large with a high incidence of neck metastases. Both these factors will result in the need for more extensive forms of treatment and poorer outcomes for patients. The number of Urgent Suspected Cancer (USC) referrals to secondary care has fortunately now returned to pre-pandemic levels but conversion rates are still low due to inappropriate use of the system. This presentation will include an interactive clinical component to help dental healthcare workers with the most effective use of the USC system for patients found to have a mucosal or soft tissue orofacial abnormality. The Delivering Better Oral Health guidance for the UK, which was updated in November 2021, will be reviewed and the changes in the sections related to mouth cancer, in particular risk factors and prevention post-treatment, presented.

Learning objectives:

Following the presentation delegates will:

• Understand the impact that the Covid-19 pandemic has had on mouth cancer
• Have an increased appreciation of the difference between cancer / potentially malignant conditions and benign mucosal disorders
• Be able to use of the USC referral system effectively
• Be aware of the cancer related information in the updated Delivering Better Oral Health guidance

This talk satisfies the GDC’s learning outcome:

C – Maintenance and development of knowledge and skill within your field of practice

Professor Michael A. O. Lewis PhD, FDSRCPS, FDSRCS (Eng), FRCPath, FFGDP(UK), FHEA, Emeritus Professor, Cardiff University

Biography

Mike Lewis served as the Professor of Oral Medicine at Cardiff University from 2000-2020.  He was also Dean of the School of Dentistry at Cardiff University, Dean of the Dental Faculty of the Royal College of Physicians & Surgeons of Glasgow and Director of the Clinical Board for Dentistry, Cardiff & Vale University Health Board. Professor Lewis has published over 200 scientific articles and co-authored six medical textbooks. He has delivered more than 600 postgraduate lectures worldwide. In addition, Mike has been President of the British Society for Oral Medicine, President of the British Society for Oral & Dental Research, Dental Representative on the Advisory Council for Misuse of Drugs (Home Office) and Dental Representative on the Scientific Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infection (Department of Health).  Professor Lewis is presently a registrant member of the General Dental Council.